サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：整形外科用生体材料の世界市場-2023年～2030年
市場調査レポート
商品コード
1373374

整形外科用生体材料の世界市場-2023年～2030年

Global Orthopedic Biomaterials Market - 2023-2030

出版日
ページ情報
英文 195 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
整形外科用生体材料の世界市場-2023年～2030年
出版日: 2023年10月18日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

バイオマテリアルとは、治療または診断検査といった医療目的のために、生体システムと相互作用するように設計された物質のことです。生体材料は、金属や高分子成分、セラミック、複合材料などを用いて、多くの化学的手法を用いて研究室で作成することができます。

整形外科用生体材料は、骨を固定するための一時的なインプラントから、永久的なインプラント材料や生体吸収性インプラントまで使用されています。一般的な整形外科用生体材料には、リン酸カルシウムセメント、生体活性ガラス、ポリマー、金属、複合材料などがあります。

市場力学

整形外科手術の増加

整形外科手術の増加は市場成長の重要な促進要因です。整形外科手術において、生体材料は、損傷した組織や病気の組織を置き換えたり再生したりするのに利用され、その生理学的性能を向上させる。

例えば、American Joint Replacement Registry（AJRR）は、2022年の年次報告書を発表しました。この報告書には、2012年以降、1,250を超える病院、外来手術センター、個人開業医グループによる、280万件を超える股関節と膝関節の手術が含まれ、全体的な累積手術件数は前年比14%の伸びを示しています。したがって、整形外科手術に使用できる生体材料の需要が増加しています。

また、WHOによると、交通事故による非致死的な負傷者は年間約2,000万～5,000万人に上る。同様に、CDCによると、2020年には、手術を必要とする非致死的傷害の外来患者がおよそ2,885,545人報告されています。このような負傷により、整形外科用バイオマテリアルの使用が増加し、市場を後押ししています。

さらに、関節リウマチや変形性関節症のような慢性疾患の症例数の増加や、製品の発売といった市場促進要因が、予測期間中に市場を牽引すると予想されます。

厳しい規制当局の承認

整形外科用生体材料市場に適用される厳しい規制基準として、市販前承認と長期にわたる臨床試験が挙げられます。このような高価で時間のかかる規制手続きは、市場開拓の総コストを引き上げる一方で、新規バイオマテリアル製品の市場投入を遅らせる。上記の要因は市場成長の妨げになると予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 整形外科手術の増加
      • YY
    • 抑制要因
      • 厳しい規制当局の承認
      • YY
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • DMI意見

第6章 COVID-19分析

第7章 材料タイプ別

  • リン酸カルシウムセメント
  • セラミックスと生体活性ガラス
  • ポリマー
  • 金属
  • 複合材料
  • その他

第8章 用途別

  • 整形外科インプラント
  • 関節置換術
  • 整形生物工学
  • 関節内補充療法
  • 生体再吸収性組織固定
  • その他

第9章 エンドユーザー別

  • 病院および診療所
  • 整形外科クリニック
  • 外来手術センター

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Stryker Corporation
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • DSM Biomedical
  • Evonik Industries AG
  • Globus Medical
  • Zimmer Biomet Holdings Inc.
  • Medbone
  • Invibio Ltd.
  • CAM Bioceramics B.V.
  • Exactech Inc.
  • DePuy Synthes

第13章 付録

目次
Product Code: MD1672

Overview

A biomaterial is a substance that has been engineered to interact with biological systems for a medical purpose, either a therapeutic or a diagnostic test. Biomaterials can be created in the lab using a number of chemical techniques using metallic or polymeric components, ceramics, or composite materials, and biomaterials can also be obtained from nature.

Orthopedic biomaterials are used from temporary implants to fix bone to permanent implant materials and bioabsorbable implants. Common orthopedic biomaterials include calcium phosphate cements, bioactive glasses, polymers, metals, and composites.

Market Dynamics

The increasing number of orthopedic surgeries

The increasing number of orthopedic surgeries acts as a significant driver for market growth. In orthopedic surgeries, biomaterials can be utilized to replace or regenerate damaged or diseased tissues in order to improve their physiological performance.

For instance, the American Joint Replacement Registry (AJRR), published its 2022 annual report that demonstrates an overall cumulative procedural growth of 14% compared to the previous year and includes over 2.8 million hip and knee procedures since 2012 from over 1,250 hospitals, ambulatory surgery centers, and private practice groups. Hence, the demand for biomaterials increases that can be used in orthopedic surgeries.

Also, according to the WHO, approximately 20-50 million people get non-fatal injuries because of road casualties yearly. Likewise, according to the CDC, roughly 2,885,545 ambulatory cases were reported with non-fatal injuries requiring surgery in 2020. Thus, due to these injuries, the use of orthopedic biomaterials increased which help to boost the market.

Furthermore, significant growth drivers such as the growing number of cases of chronic diseases like rheumatoid arthritis, and osteoarthritis, and, product launches are expected to drive the market in the forecast period.

Stringent regulatory approvals

Pre-market approval and lengthy clinical trials are among the strict regulatory criteria that apply to the orthopedic biomaterial market. These expensive and time-consuming regulatory procedures raise the overall cost of development while delaying the release of novel biomaterial products into the market. The above factors are expected to hamper the market growth.

Segment Analysis

The global orthopedic biomaterials market is segmented based on material type, application, end users and region.

Calcium phosphate cement accounted for approximately 47.8% of the market share

Calcium phosphate cement is a bioactive and biodegradable grafting material in the form of powder and liquid. Calcium phosphate cements are expected to hold the largest market share over the period forecast owing to increasing new orthopedic biomaterial launches and technical advancements.

For instance, in July 2022, Curasan AG launched the CERASORB CPC (Calcium Phosphate Cement) Bone Void Fillers for maxillofacial, orthopedic, and trauma surgery. CERASORB CPC is a synthetic, biocompatible, osteoconductive, and bioresorbable mineral bone cement composed of calcium and phosphate salts finely dispersed in a biocompatible oil.

Additionally, in May 2022, Granulab (M) Sdn Bhd launched Malaysia's first halal-certified synthetic bone cement called Prosteomax. It is an innovative calcium phosphate-based synthetic bone cement that has been certified halal by the Islamic Development Department Malaysia.

Geographical Analysis

North America is expected to hold a significant position in the global orthopedic biomaterials market share

The global orthopedic biomaterials market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa.

North America has maintained a significant market proportion due to factors such as the rising prevalence of orthopedic surgeries, and product launches, this trend is anticipated to continue throughout the forecast period.

For instance, in April 2023, Abyrx, Inc. received U.S. FDA clearances for the MONTAGE Settable, Resorbable Bone Putty as both a bone void filler and cranial bone cement. MONTAGE is a hand-moldable, hardening putty that, within minutes after mixing, develops bone-like characteristics and offers a unique intraoperative application.

Additionally, in February 2022, Orthofix Medical Inc. launched the Opus BA, a synthetic bioactive bone graft solution for cervical and lumbar spine fusion procedures. Opus BA can be used to fill skeletal system gaps or holes that are not essential to the stability of the bony structure.

COVID-19 Impact Analysis:

The COVID-19 pandemic has had a significant impact on the global orthopedic biomaterials market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular diagnoses, treatments, biomaterial launches, and consultations worldwide. With the outbreak of the pandemic, many pharmaceutical or medical device manufacturing units faced labor shortages and were unable to travel to work due to lockdown restrictions. Therefore, owing to the above factors, the orthopedic biomaterials market is expected to be moderately affected over the forecast period.

Competitive Landscape

The major global players in the market include: Stryker Corporation, Koninklijke DSM N.V., Evonik Industries AG, Globus Medical, Zimmer Biomet Holdings Inc., Medbone, Invibio Ltd., CAM Bioceramics B.V., Exactech Inc., DePuy Synthes among others.

Key Developments

  • In June 2023, Invibio Biomaterial Solutions collaborated with Paragon Medical to manufacture composite PEEK-OPTIMA Ultra-Reinforced medical trauma devices.
  • In August 2022, Oxford Performance Materials in collaboration with SINTX Technologies successfully developed a new class of orthopedic coatings. These coatings are targeted at overcoming the clinical limitations of metallic implants.
  • In September 2020, Evonik introduced a unique osteoconductive polyether ether ketone (PEEK) for the medical technology market that improves the fusion between bone and an implant.

Why Purchase the Report?

  • To visualize the global orthopedic biomaterials market segmentation based on material type, application, end users and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of orthopedic biomaterials market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global orthopedic biomaterials market report would provide approximately 61 tables, 63 figures, and 185 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Material Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End Users
  • 3.4. Snippet by Region

4. Market Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The increasing number of orthopedic surgeries
      • 4.1.1.2.
    • 4.1.2. Restraints
      • 4.1.2.1. Stringent regulatory approvals
      • 4.1.2.2.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Material Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.1.2. Market Attractiveness Index, By Material Type
  • 7.2. Calcium Phosphate Cements*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ceramics & Bioactive Glasses
  • 7.4. Polymers
  • 7.5. Metal
  • 7.6. Composites
  • 7.7. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Orthopedic Implants*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Joint Replacement
  • 8.4. Orthobiologics
  • 8.5. Viscosupplementation
  • 8.6. Bio-resorbable Tissue Fixation
  • 8.7. Others

9. By End Users

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 9.1.2. Market Attractiveness Index, By End Users
  • 9.2. Hospital And Clinics*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Orthopedic Clinics
  • 9.4. Ambulatory Surgical Centers

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Stryker Corporation
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. DSM Biomedical
  • 12.3. Evonik Industries AG
  • 12.4. Globus Medical
  • 12.5. Zimmer Biomet Holdings Inc.
  • 12.6. Medbone
  • 12.7. Invibio Ltd.
  • 12.8. CAM Bioceramics B.V.
  • 12.9. Exactech Inc.
  • 12.10. DePuy Synthes

LIST NOT EXHAUSTIVE.

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us